Unlock better outcomes with real-world closed claims data from taXonomy
As high-value therapies become the new norm,life sciences teams need closed claims data that...
As high-value therapies become the new norm,life sciences teams need closed claims data that...
Open claims and closed payer claims data are essential for understanding the status and activities...
The FDA often requires some sort of post-market surveillance for medical devices to determine the...
Real-world data (RWD) offers a multitude of use cases that can benefit pharmaceutical companies...
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
Two years ago, HealthVerity launched the Maternal Outcomes Masterset (MOM) to address the...
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
The COVID-19 pandemic illustrated how vital government communications can be for effective public...
As real-world data (RWD) continues to be increasingly utilized by the pharmaceutical industry and...
RWE and HEOR teams face increasing pressure to produce evidence that holds up beyond internal analysis. As real-world data informs decisions subject to external review, expectations for data quality have changed.